UM: Nonalcoholic Fatty Liver Disease: Miller School Researchers Target a Silent Epidemic

UM: Nonalcoholic Fatty Liver Disease: Miller School Researchers Target a Silent Epidemic

Nonalcoholic fatty liver disease, or NAFLD, affects 100 million Americans and millions of others worldwide. The disease is costing lives, health and an estimated $32 billion in U.S. health care costs annually.

Full Story

Related posts

FIU Researchers deploy new tech to explore depths of Gulf of Mexico

FIU marine scientist Kevin Boswell and a multi-institution research team will deploy experimental technology next…

USF Health Neurology and VuEssence collaborate on stroke early-detection test

The diagnostic blood test being developed is intended to speed treatment critical to improving ischemic…

UM: Phase III Trial Evaluating Arimoclomol for ALS Patients Reaches Full Enrollment

An international phase III clinical trial evaluating the drug Arimoclomol for the treatment of amyotrophic…